Advent Life Sciences
General contacts
Investor type
VC
Founded
2005
AUM
-
Location
United Kingdom
$1-5 m
Investment Ticket
3-5 years
Investment Horizon
Seed,
Series B,
Series A
Investment Stage
Sale to strategic investor,
IPO
Exit Strategy
Investor profile last updated: 06 December, 2025
Profile
Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and inve stment success through turning break-through science into approved medicines or medical products. We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.
Industry
Region of investment
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Advent Life Sciences
Where is Advent Life Sciences located?
Advent Life Sciences is located in United Kingdom.
When was Advent Life Sciences founded?
Advent Life Sciences was founded in 2005.
What sectors and industries does Advent Life Sciences invest in?
Advent Life Sciences invests in companies and startups in Biotechnology, Fashion/Beauty, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech.
What is Advent Life Sciences geographical focus of investments?
Advent Life Sciences invests in companies and startups in North America, Europe.
At what stages of companies and startups does Advent Life Sciences typically invest in?
Advent Life Sciences invests in companies and startups at Seed, Series B, Series A.
What is the usual amount of Advent Life Sciences investment?
Advent Life Sciences usually invests $1-5 m on average.